MINM yields 55.40% · PFE yields 6.20%● Live data
📍 MINM pulled ahead of the other in Year 1
Combined, MINM + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MINM + PFE for your $10,000?
Minim, Inc., together with its subsidiaries, designs, develops, sells, and supports an Internet of Things security platform in North America and internationally. It offers hardware products, including cable modems, cable modem/routers, gateways, mobile broadband modems, wireless routers, multimedia over coax adapters, mesh home networking devices, and other local area network products. The company also provides Minim mobile applications for end users to personalize and monitor their home and office network for speed testing, data usage tracking, security alerts, malware blocking, privacy settings, and parental controls; and Minim web application that enables technical support representatives of Internet Service Providers (ISPs) and businesses to offer remote support with network insights. In addition, it offers Minim API suite and MinimOS for third-party hardware vendors, ISPs, and other partners to integrate with the Minim platform and functionality; to manage their own account data; and to integrate with third-party router firmware. The company offers its products under the ZOOM, Motorola, and Minim brands. It sells its products through direct sales force and commissioned independent sales representatives to retailers; and retailers, distributors, ISPs, individual businesses, service providers, value-added resellers, PC system integrators, original equipment manufacturers, channel resellers, electronics distributors, and e-commerce platforms. The company was formerly known as ZoomTelephonics, Inc. and changed its name to Minim, Inc. in June 2021. Minim, Inc. was incorporated in 1977 and is headquartered in Manchester, New Hampshire.
Full MINM Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.